查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433328

2023-2030 年全球无引线心律调节器市场

Global Leadless Pacemakers Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030 年），全球无引线心律调节器市场将以 3.6% 的CAGR成长。主要因素之一归因于市场成长，包括老年人口的增加、心血管疾病（CVD）盛行率的增加、有利的政府倡议和政策以及新型和增强型技术产品的推出。据世界卫生组织称，2019 年估计有 1,790 万人死于心血管疾病，占全球死亡率的 32%。此外，2022 年 11 月，《老年人口统计：美国老化肖像》一文报道，有 5,410 万名成年人（占美国人口的 16.3%）是老年人，其中包括 65 岁或以上的老年人。预计到 2040 年，老年人口将增加至 22%，到 2060 年将增加至 25%。此外，越来越多的产品推出以满足对无引线起搏器的需求。 2023 年 9 月，Beebe Healthcare 推出了无引线心律调节器，并成为特拉华州第一家植入该设备的公司。特拉华州第一位接受 Micra AV2 无引线起搏器的心臟病患者在 Beebe 接受微创植入手术就是一个例证。

细分市场前景

全球无引线心律调节器市场按起搏室、产品和最终用途进行细分。根据起搏室，市场分为单室和双室。根据产品，市场细分为 micra 经导管起搏系统和 nanostim 无引线心律调节器。此外，根据最终用途，市场细分为医院、门诊手术中心等。其他包括心臟中心。在最终用途中，预计医院细分市场将在预测期内占据最大的市场份额。该细分市场的大部分份额归功于较低的成本、较高的效率和可用性。

Micra 经导管起搏系统细分市场预计将在全球无引线起搏器市场中占据相当大的份额

在这些产品中，Micra 经导管起搏系统细分市场预计将在预测期内成长。 Micra 是一种单腔心律调节器，其大小与维生素一样，可以直接植入心臟，无需植入导线。此细分市场的推动因素是心血管疾病负担日益增加、植入后併发症极少以及易于取出，预计将刺激市场。英国心臟基金会（BHF）2023年1月公布的资料报告称，2021年最常见的心血管疾病是冠心病（缺血性）心臟病（2019年全球患病率估计为2亿）、外周动脉（血管）疾病（1.1亿） 、中风（1亿）和心房颤动（6000万）。此外，报告也显示，北美心臟和循环系统疾病盛行率为4,800万，欧洲为1亿，非洲和中东为9,800万，拉丁美洲为4,800万，亚洲和澳洲为是3.4亿。此外，核准的增加也扩大了有资格接受 Micra TPS 的患者数量。例如，2022 年 1 月，医疗保健技术先驱美敦力公司 (Medtronic plc) 获得日本厚生劳动省批准销售 Micra (TM) AV 经导管起搏系统并获得报销。

区域展望

全球无引线心律调节器市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本） 、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于对无引线起搏器的需求不断增长，预计欧洲在预测期内将出现增长，老年人口、心血管疾病患病率的增加、医疗保健支出的增加，推动了欧洲无引线心律调节器市场的发展。

北美地区预计全球无引线起搏器市场将以显着的复合CAGR成长

预计在预测期内，北美将在无引线起搏器市场中占据显着份额。推动北美市场的重要因素是整个北美 CVD 数量的不断增加，预计这将对未来几年无引线起搏器市场的成长产生积极影响。根据美国心臟协会的数据，心血管疾病仍然是美国的首要死因，2020 年导致 928,741 人死亡。此外，心臟相关疾病数量的增加和技术进步进一步推动了该地区的市场。 2020 年，在美国，冠状动脉心臟病 (CHD) 是美国 CVD 死亡的主要原因 (41.2%)，其次是中风 (17.3%)、其他 CVD (16.8%)、高血压 (12.9%) ）、心臟衰竭（9.2 %）。

市场参与者展望

服务于无引线起搏器市场的主要公司包括 Abbott Laboratories、Medtronic PLC、Boston Scientific Corp.、MicroPort Scientific Corp. 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2022年10月，Ceryx Medical Ltd与Osypka Medical合作开发心臟节律设备。 Ceryx 和 Osypka 开发了一种心臟起搏装置，改变了心臟衰竭和其他心臟病患者的治疗方式。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球无引线起搏器市场的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Boston Scientific Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Medtronic plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • MicroPort Scientific Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按起搏室分類的全球无引线心律调节器市场
    • 单室
    • 双室
  • 按产品分類的全球无引线心律调节器市场
    • Micra 经导管心律调节系统
    • Nanostim 无引线心律调节器
  • 按最终用途分類的全球无引线心律调节器市场
    • 医院
    • 门诊手术中心
    • 其他（心臟中心）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • BIOTRONIK SE & Co KG
  • Beebe Healthcare
  • EBR Systems Inc.,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • LivaNova PLC
  • OSYPKA MEDICAL GmbH
  • Telectronics Pacing Systems, Inc.
  • Terumo Corp.
Product Code: OMR2028005

Global Leadless Pacemakers Market Size, Share & Trends Analysis Report by Pacing Chamber (Single-chamber Pacemaker, Dual-chamber Pacemaker), By Product, (Micra Transcatheter Pacing System and Nanostim Leadless Pacemaker), by End-Use (Hospitals, Ambulatory Surgical Centers, and Others), Forecast Period (2023-2030)

The global leadless pacemakers market is anticipated to grow at a CAGR of 3.6% during the forecast period (2023-2030). One of the major factors are attributed to the market growth including the rising geriatric population, increasing prevalence of cardiovascular disease (CVDs), favorable government initiatives and policies, and the introduction of new and enhanced technological products. According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global mortalities. Further, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 or older. The senior population is expected to rise to 22% by 2040 and 25% by 2060. In addition, the increasing products launches to cater the demand for leadless pacemakers. In September 2023, Beebe Healthcare introduced leadless pacemaker and becomes first in Delaware to implant the device. That was exemplified when the first cardiac patient in Delaware to receive the Micra AV2 leadless pacemaker underwent the minimally invasive implantation procedure at Beebe.

Segmental Outlook

The global leadless pacemakers market is segmented by pacing chamber, product, and end-use. Based on the pacing chamber, the market is sub-segmented into single chamber, and dual chamber. Based on the product, the market is sub-segmented into micra transcatheter pacing system and nanostim leadless pacemaker. Further, based on end-use, the market is sub-segmented into hospitals, ambulatory surgical centers, and others. Where others include cardiac centers. Among the end-use, the hospitals sub-segment is anticipated to hold the largest market share during the forecast period. The large share of this segment is credited to the lower costs, higher efficiency, and availability.

The Micra Transcatheter Pacing System Sub-Segment is Anticipated to Hold a Considerable Share of the Global Leadless Pacemakers Market

Among the products, micra transcatheter pacing system sub-segment expected to grow over the forecast period. Micra is a single-chamber pacemaker specifically the size of a vitamin and can be implanted directly into the heart, eliminating the need for the leads to be implanted. The segment is driven by the owing to the increasing burden of CVDs, minimal post-implantation complications, and easy retrieval, which is projected to encourage the market. The British Heart Foundation (BHF) data published in January 2023 reported that in 2021, the most common cardiovascular conditions are coronary (ischaemic) heart disease (global prevalence estimated at 200 million in 2019), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). Additionally, the report revealed that the prevalence of heart and circulatory diseases in North America was 48 million, in Europe it was 100 million, in Africa and middle east it was 98 million, in Latin America it was 48 million, and in Asia and Australia it was 340 million. Furthermore, the increasing approvals expands the number of patients who are eligible to receive the Micra TPS. For instance, in January 2022, Medtronic plc, a pioneer in healthcare technology, received approval from Japan's Ministry of Health, Labor and Welfare for the sale and reimbursement of the Micra™ AV transcatheter pacing system.

Regional Outlook

The global leadless pacemakers market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Europe is anticipated to grow over the forecast period, owing to the growing demand for leadless pacemakers, increasing geriatric population, , increasing prevalence of CVDs, the rising healthcare expenditure, driving the leadless pacemakers market in the Europe.

The North America Region is Expected to Grow at a Significant CAGR in the Global Leadless Pacemakers Market

North America is expected to hold a prominent share in the leadless pacemakers market during the forecast period. The significant factors fueling the North America market is the rising number of CVDs across the North America is estimated to positively impact the leadless pacemakers market growth in upcoming years. According to the American Heart Association, CVDs remains as the leading cause of death in the US, accounted for 928,741 deaths in the year 2020. Additionally, the increasing number of heart-related disorders and technological advancements are further driving the market in the region. In 2020 in the US, coronary heart disease (CHD) was the leading cause (41.2%) of deaths attributable to CVD in the US, followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%).

Market Players Outlook

The major companies serving the leadless pacemakers market include Abbott Laboratories, Medtronic PLC, Boston Scientific Corp., MicroPort Scientific Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2022, Ceryx Medical Ltd, partnered with Osypka medical to develop heart pacing device. Ceryx and Osypka developed a heart pacing device that changed the way patients with heart failure and other cardiac conditions are treated.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global leadless pacemakers market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Boston Scientific Corp.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Medtronic plc
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. MicroPort Scientific Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Leadless Pacemakers Market by Pacing Chamber
    • 4.1.1. Single Chamber
    • 4.1.2. Dual Chamber
  • 4.2. Global Leadless Pacemakers Market by Product
    • 4.2.1. Micra Transcatheter Pacing System
    • 4.2.2. Nanostim Leadless Pacemaker
  • 4.3. Global Leadless Pacemakers Market by End-Use
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgical Centers
    • 4.3.3. Other (Cardiac Centers)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. BIOTRONIK SE & Co KG
  • 6.2. Beebe Healthcare
  • 6.3. EBR Systems Inc.,
  • 6.4. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 6.5. LivaNova PLC
  • 6.6. OSYPKA MEDICAL GmbH
  • 6.7. Telectronics Pacing Systems, Inc.
  • 6.8. Terumo Corp.

LIST OF TABLES

  • 1. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 2. GLOBAL SINGLE CHAMBER LEADLESS PACEMAKER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL DUAL CHAMBER LEADLESS PACEMAKER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 5. GLOBAL MICRA TRANSCATHETER PACING SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL NANOSTIM LEADLESS PACEMAKER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 8. GLOBAL LEADLESS PACEMAKERS FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL LEADLESS PACEMAKERS FOR AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL LEADLESS PACEMAKERS FOR OTHER END-USE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 16. EUROPEAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. EUROPEAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 18. EUROPEAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 19. EUROPEAN LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 20. ASIA-PACIFIC LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PACING CHAMBER, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL LEADLESS PACEMAKERS MARKET SHARE BY PACING CHAMBER, 2022 VS 2030 (%)
  • 2. GLOBAL SINGLE CHAMBER LEADLESS PACEMAKER MARKET SHARE, 2022 VS 2030 (%)
  • 3. GLOBAL DUAL CHAMBER LEADLESS PACEMAKER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL LEADLESS PACEMAKERS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 5. GLOBAL MICRA TRANSCATHETER PACING SYSTEM MARKET SHARE, 2022 VS 2030 (%)
  • 6. GLOBAL NANOSTIM LEADLESS PACEMAKER MARKET SHARE, 2022 VS 2030 (%)
  • 7. GLOBAL LEADLESS PACEMAKERS MARKET RESEARCH AND ANALYSIS BY END-USE, 2022 VS 2030 (%)
  • 8. GLOBAL LEADLESS PACEMAKERS FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL LEADLESS PACEMAKERS FOR AMBULATORY SURGICAL CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL LEADLESS PACEMAKERS FOR OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL LEADLESS PACEMAKERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. US LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. CANADA LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. UK LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. FRANCE LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. GERMANY LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. ITALY LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. SPAIN LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. REST OF EUROPE LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. INDIA LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. CHINA LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. JAPAN LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SOUTH KOREA LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD LEADLESS PACEMAKERS MARKET SIZE, 2022-2030 ($ MILLION)